You are here
Drug Safety Issues
Device Use Should Continue–Remote Monitoring Benefits Outweigh Cyberattack Risks
41,000+ Medical Device Reports of Deaths, Serious Injuries, and Malfunctions in 7 Years
Purportedly Sterile Products Made in Unsanitary Conditions, Judge Says
Safety Risks for Patients Undergoing Mastectomies and Cancer Surgeries
Antiepilectic Drug Given as Adjunct Therapy in Adults With Certain Seizure Types
Particulate Matter Identified as Glass Discovered in Agent
Injecting Corrupted Drug Could Cause Phlebitis, Pulmonary Embolic Events
Patients with MS Suffered Stroke, Blood Vessel Tearing in Head and Neck After Receiving Drug
Lack of Sterility Assurance Cited
Use of Non-Approved Pain Medications Could Cause Dosing Errors, Pump Failures
NDEA, a Known Carcinogen, Discovered During FDA Testing
Mixup with Losartan Discovered in Bottles
Warning Letters Issued for Products Resembling Juice Boxes, Cookies and Candy
Dangers After Donor Stem Cell Transplant
Some studies had linked the device to harmful side effects.
Part of an ongoing effort to better oversee use of compounded medications.
An impurity has been found to be carcinogenic.
Agency says products for sexual enhancement, weight loss, and bodybuilding have hidden drugs and chemicals.
Agency cites serious safety risk, lack of benefit
Agency cites deficiencies; Cantrell criticizes communication
Biogen, AbbVie blame reports of inflammatory brain disorders
Death toll linked with Asian plant rises to 44
Some liver-disease patients face risk of injury
Society for Healthcare Epidemiology of America provides guidance
Atcell is derived from adipose and meant for autologous use
FDA announces that four studies showed no increased risk of death
Device blamed for spreading uterine cancer
Setback follows announcement of adverse patient outcomes with dengue vaccine
Treatment targets advanced or metastatic HR-positive, HER2-negative cases
Patients with impaired liver function receiving too many doses